Maximizing the Use and Business Value of Patents

Size: px
Start display at page:

Download "Maximizing the Use and Business Value of Patents"

Transcription

1 Maximizing the Use and Business Value of Patents Getting from Patents to Innovation Corey Salsberg Head International IP Policy Medellín, Colombia, April 16, 2015

2 Who We Are: Novartis at a Glance Novartis is a global healthcare company whose mission is to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering, and to enhance the quality of life for patients. Headquarters: Basel, Switzerland 3 Main Global Operating Divisions Pharmaceuticals Innovative Rx Alcon Eyecare 123,000+ full-time associates from 150+ countries Sandoz Generics + Biosimilars Operations in over 140 countries (sales in 180 countries) 2

3 Novartis: Innovation and Patient Health Our core medicines reach more than 1 billion people annually. Consistent with our focus on patients, we reach hundreds of millions more through our special access programs. Our ability to continue to address patient needs depends on innovation. [B]efore Gleevec, only 30% of patients with CML [chronic myelogenous leukemia] survived for even five years after being diagnosed. With Gleevec, that number rose to at least 89%. Pray, L. (2008) Gleevec: the breakthrough in cancer treatment. Nature Education 1(1):37 In 2014, we teamed up with Google to develop smart lens technology. In 2006, Sandoz launched the firstever biosimilar in the EU Omnitrope (somatropin), and in March 2015 secured FDA approval for the first biosimilar in US history, Zarxio (filgrastim). At heart, we are an innovation company. More than 200 R&D projects are underway, with 20 compounds in development, and 5 FDA breakthrough therapy designations (2 in 2014) 3

4 What do these have to do with patents? The very first official thing I did, in my administration and it was on the very first day of it too was to start a patent office; for I knew that a country without a patent office and good patent laws was just a crab, and couldn t travel any way but sideways or backwards. Time travel Scrap books Camelot A Connecticut Yankee in King Arthur s Court (1889) 4

5 The Beauty of the Patent System in the Words of the US Founding Fathers The utility of th[is] clause will scarcely be questioned.... The right to useful inventions... belong[s] to the inventors. The public good fully coincides... with the claims of the individuals. James Madison, Federalist No. 43,

6 Which Was Mark Twain s Most Profitable Book? A. Twain s The Adventures patented self-pasting of Tom Sawyer scrapbook (1873) sold over 25,000 copies, earning more money in his lifetime than any other of his other books. B. The Adventures of Huckleberry Finn C. Life on the Mississippi This was well enough for a book that did not contain a single word that critics could praise or condemn. D. A Connecticut Yankee in King Arthur s Court 6

7 Do Patents = Business Success? A Means, Not an End Not all inventions are innovations. Invent = Create something new Innovate = Put an invention to practical use Innovation requires more than patents! US Patent No. 6,293,874 US Patent No. 5,830,035 UK Patent GB

8 Getting From Patents to Innovation What Can Patents Do for Entrepreneurs? 1. Provide a limited term of market exclusivity through which to recoup investment and establish customer loyalty. Case Study: In the 1980s, Brazil s Achē isolated a compound from an Amazonian plant that showed promise as an effective pain reliever but it was not developed until after 1996, when Brazil began to recognize pharmaceutical patents under TRIPs. The drug became Achéflan, the first patented medicine ever developed by a Brazilian firm. All trademarks are property of their respective holders. Achéflan was an instant hit with professional football players 8

9 Getting From Patents to Innovation What Can Patents Do for Entrepreneurs? 2. Enable risk-taking through R&D Risk leads to innovation... - More than 90% of all successful innovations start off as failures Innovation leads to business success and transforms and saves lives Mark Twain s sister died of a fever when he was 4. 3 years later his brother died from the same. At age 8, a measles epidemic led Twain to expose himself to infection by sharing a bed with his infected friend. Cholera killed at least 24 people in his small town. In 1847 his father died of pneumonia. - In our industry, risky and expensive R&D fueled by patents has transformed medicine Why else take risks? 460 BC s AD 1880s - Present Average life span of all-sized companies in Japan and Europe is only 12.5 years Average life of a multinational (Fortune 500) is around 45 years Of the top 500 U.S. firms in 1980, only 202 had survived by the year

10 Getting From Patents to Innovation What Can Patents Do for Entrepreneurs? 3. Enable entrepreneurs to innovate in directions where other forms of IP (e.g. trade secrets, TMs, know-how) do not work. Lessons from History: The 19 th Century World s Fairs Moser, P., How do Patent Laws Influence Innovation? National Bureau of Economic Research 33,000 examples of real innovations from 1851 and 1876 World s Fairs Countries w/o patent laws were innovative, but only where secrecy worked (food processing, scientific instruments) Countries with patent systems innovated much more broadly (e.g. machinery, where secrecy does not work). As scientific instruments grew dependent on machinery, countries w/o patent laws stopped making them, moved further into food processing. Secrecy does not work well for many fields today (or for society)! 10

11 Getting From Patents to Innovation What Can Patents Do for Entrepreneurs? 4. Attract investment to convert inventions into innovations (enable product development) Beam Brush Toothbrush with built-in-sensor and link to mobile app. Records duration of teeth brushing Connects to smartphone Tracks dental habits Sends notice when kids have brushed Use toothbrush as game controller After filing patent applications beginning in 2011, inventor was able to secure requisite venture capital to fund development, making the product a reality. Sources: Reuters, Small businesses likely to benefit from patent law overhaul, Sept. 25, 2012; All trademarks are property of their respective holders. 11

12 Getting From Patents to Innovation What Can Patents Do for Entrepreneurs? 5. Provide licensing income for those who do not/cannot practice inventions directly Finances career inventors or companies (enables anyone to become a career inventor) Thomas Edison licensed or assigned most of his patented inventions to third parties in order to fund his full-time R&D efforts Over 70% of the great inventors of the 19 th century had only a primary school education (half had no formal schooling at all). Charles Goodyear invented and patented the process for vulcanized rubber (1844), but never manufactured or sold rubber products In 1894, American Bell Telephone Co. licensed 73 patents from outside inventors, developing only 12 inventions in-house Image from Scientific American (Aug. 12, 1854), p Sources: A. Mossoff, The History of Patent Licensing and Secondary Markets in Patents, George Mason U. School of Law, Dec. 2013; H. Nothhaft & D. Kline, Was Thomas Edison a Patent Troll?, IP Watchdog June 1,

13 Getting From Patents to Innovation What Can Patents Do for Entrepreneurs? 6. Increase value of overall enterprise (for eventual investment or purchase) 1880s: Herman Hollerith obtained series of patents on tabulating machine technology which became the standard for tabulating and computing data input. 1911: Financier Charles Flint took notice and bought the company for $2.3m. Merged with 3 other companies, and formed Computing Tabulating Recording (CTR) Company. 1924: Business spread to Europe, South America, Asia and Australia. The company was renamed. 13 All trademarks are property of their respective holders.

14 Getting From Patents to Innovation What Else Can Patents Do for Entrepreneurs? 7. Knowledge dissemination (compare with trade secrets) 8. Enabling improvements or new products through cross-licensing, JVs, collaborations. 9. Defining scope and allocation of rights in JVs and partnerships. 14

15 Increasing the Odds of Business Success: Seven Steps to IP Nirvana Use IP Counsel incl. WIPO-WEF IAP Stay close to the business Manage IP ownership File IP applications ASAP Use NDAs when approaching others Take care when publishing inventions Adopt a state of IP mindfulness (which IPR and when?) 15

Targeting Cancer: Innovation in the Treatment of Chronic Myelogenous Leukemia EXECUTIVE SUMMARY. New England Healthcare Institute

Targeting Cancer: Innovation in the Treatment of Chronic Myelogenous Leukemia EXECUTIVE SUMMARY. New England Healthcare Institute Targeting Cancer: Innovation in the Treatment of Chronic Myelogenous Leukemia New England Healthcare Institute NEHI Innovation Series March 2004 Executive Summary From drugs and medical devices, to information

More information

CAS Chemistry Research Report Delivering the latest trends in global chemistry research

CAS Chemistry Research Report Delivering the latest trends in global chemistry research Delivering the latest trends in global chemistry research Human Genome Discoveries Spur Growth of Cancer Treatments www.cas.org Strength of the Human Genome Project and Targeted Drugs In, President Clinton

More information

Why Are Drugs So Expensive? Learning About the Drug Development Process

Why Are Drugs So Expensive? Learning About the Drug Development Process Why Are Drugs So Expensive? Page 1 of 92 Why Are Drugs So Expensive? Learning About the Drug Development Process written by: Ann Newman Seventh Street Development Group This product is for your Personal

More information

You re One in Seven Billion!

You re One in Seven Billion! You re One in Seven Billion! We ve all heard the expression, You re one in a million!. With the ever-growing number of people on the planet, it might be more accurate to say, You re one in seven billion!

More information

Intellectual Property How to Protect Your Discovery. Technology Transfer Office

Intellectual Property How to Protect Your Discovery. Technology Transfer Office Intellectual Property How to Protect Your Discovery Technology Transfer Office Technology Transfer In the course of doing research & development you make discoveries BloodCenter Research Foundation protects

More information

INTELLECTUAL PROPERTY MANAGEMENT: AN IMPORTANT TOOL FOR SMALL AND MEDIUM ENTERPRISES

INTELLECTUAL PROPERTY MANAGEMENT: AN IMPORTANT TOOL FOR SMALL AND MEDIUM ENTERPRISES INTELLECTUAL PROPERTY MANAGEMENT: AN IMPORTANT TOOL FOR SMALL AND MEDIUM ENTERPRISES SIMONA GABOR LUCIAN BLAGA UNIVERSITY OF SIBIU, România gabor_simona@yahoo.com Abstract: An essential factor affecting

More information

OVERVIEW OF CONTRACTUAL AGREEMENTS FOR THE TRANSFER OF TECHNOLOGY

OVERVIEW OF CONTRACTUAL AGREEMENTS FOR THE TRANSFER OF TECHNOLOGY OVERVIEW OF CONTRACTUAL AGREEMENTS FOR THE TRANSFER OF TECHNOLOGY I. Introduction 1. Simply put, technology transfer is the process by which a technology, expertise, knowhow or facilities developed by

More information

The Biotech Business Life Cycle. The Lawyer s Role as Counselor and Advisor

The Biotech Business Life Cycle. The Lawyer s Role as Counselor and Advisor The Biotech Business Life Cycle and The Lawyer s Role as Counselor and Advisor ASU February 15, 2010 1 BIOTECH BUSINESS CYCLE AN INTERDISCIPLINARY APPROACH TO LEGAL REPRESENTATION Intellectual Property

More information

Many people think that Ideas constitute an Invention. In this module, we make the distinction between an idea and an invention more clear.

Many people think that Ideas constitute an Invention. In this module, we make the distinction between an idea and an invention more clear. Many people think that Ideas constitute an Invention. In this module, we make the distinction between an idea and an invention more clear. 1 2 The invention process for the successful inventor should start

More information

Life with MS: Mastering Early Treatment

Life with MS: Mastering Early Treatment Life with MS: Mastering Early Treatment Essential Information About MS Multiple sclerosis (MS) is a disease that attacks the central nervous system (CNS). Approximately 2.5 million people worldwide and

More information

China IPR SME Helpdesk Stakeholder Meeting

China IPR SME Helpdesk Stakeholder Meeting China IPR SME Helpdesk Stakeholder Meeting Brussels, 21 January 2013 21 January 2013 1 Presentation Outline The China IPR SME Helpdesk Initiative a recap Helpdesk Evolution Services at a glance 2012 Achievements

More information

Managing Innovation & Intellectual Property Rights. Document author Assured by Review cycle. Executive Team. 1. Introduction...3. 2. Purpose...

Managing Innovation & Intellectual Property Rights. Document author Assured by Review cycle. Executive Team. 1. Introduction...3. 2. Purpose... Managing Innovation & Intellectual Property Rights Board library reference Document author Assured by Review cycle P107 Liam Stallard Executive Team Company Secretary 3 Years This document is version controlled.

More information

Scott Byrne & Rachel Weeks G400: Pharma Report 10/22/09 Direct to Consumer Advertising: The Affect on the Pharmaceutical Industry

Scott Byrne & Rachel Weeks G400: Pharma Report 10/22/09 Direct to Consumer Advertising: The Affect on the Pharmaceutical Industry Scott Byrne & Rachel Weeks G400: Pharma Report 10/22/09 Direct to Consumer Advertising: The Affect on the Pharmaceutical Industry A Glance at the Pharmaceutical Industry The pharmaceutical industry is

More information

Mywish Maredia, Frederic Erbisch, Anwar Naseem, Amie Hightower, James Oehmke, Dave Weatherspoon, & Christopher Wolf 1

Mywish Maredia, Frederic Erbisch, Anwar Naseem, Amie Hightower, James Oehmke, Dave Weatherspoon, & Christopher Wolf 1 AgBioForum Volume 2, Number 3 & 4 1999 Pages 247-252 PUBLIC AGRICULTURAL RESEARCH AND THE PROTECTION OF INTELLECTUAL PROPERTY: ISSUES AND OPTIONS Mywish Maredia, Frederic Erbisch, Anwar Naseem, Amie Hightower,

More information

Pfizer Oncology. Guest Expert: Louis Denis, MD Director of Clinical Research, Pfizer Oncology. www.wnpr.org. www.yalecancercenter.

Pfizer Oncology. Guest Expert: Louis Denis, MD Director of Clinical Research, Pfizer Oncology. www.wnpr.org. www.yalecancercenter. Pfizer Oncology Guest Expert: Louis, MD Director of Clinical Research, Pfizer Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Ken Miller. I am Bruce

More information

What is a Stem Cell Transplantation?

What is a Stem Cell Transplantation? What is a Stem Cell Transplantation? Guest Expert: Stuart, MD Associate Professor, Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Ken. I am

More information

Intellectual Property The Basis for Venture Capital Investments

Intellectual Property The Basis for Venture Capital Investments Intellectual Property The Basis for Venture Capital Investments Mario W. Cardullo, P.E. 1 While technology has been seen as one of the engines for the dramatic economic growth and productivity the United

More information

Private Healthcare. How To Apply For IFC Financing About IFC CREATING OPPORTUNITY IN EMERGING MARKETS

Private Healthcare. How To Apply For IFC Financing About IFC CREATING OPPORTUNITY IN EMERGING MARKETS How To Apply For IFC Financing About IFC A company or entrepreneur seeking to establish a new health project or expand an IFC, a member of the World Bank Group, is the largest global development existing

More information

ORIGINAL: English DATE: November 1999 E GOVERNMENT OF TRINIDAD AND TOBAGO WORLD INTELLECTUAL PROPERTY ORGANIZATION WIPO NATIONAL SEMINAR ON INNOVATION PROMOTION organized by the World Intellectual Property

More information

contents 02 CHAIRMAN S LETTER 08 2014 At a glance Performance 22 Performance Summary 30 Division Performance

contents 02 CHAIRMAN S LETTER 08 2014 At a glance Performance 22 Performance Summary 30 Division Performance Annual Report 2014 our mission Our mission is to care and cure. We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the

More information

Pennino Corporation TECHNOLOGY TO IMPROVE LIFE

Pennino Corporation TECHNOLOGY TO IMPROVE LIFE Pennino Corporation TECHNOLOGY TO IMPROVE LIFE Agenda The Opportunity Highlights Corporate Profile NYU Relationship Obesity and Diabetes Graphics and Facts Next Stage of Development Efficacy and Safety

More information

The basics of an Intellectual Property Program

The basics of an Intellectual Property Program Technology Insights The basics of an Intellectual Property Program Inside: Features of an Intellectual Property Program What is intellectual property? Role of CEOs and CFOs Foreign patents or copyrights

More information

The Adventures of Huckleberry Finn Test. 1. Who wrote The Adventures of Huckleberry Finn? a. Tom Sawyer b. Mark Twain c. Tom Jones d.

The Adventures of Huckleberry Finn Test. 1. Who wrote The Adventures of Huckleberry Finn? a. Tom Sawyer b. Mark Twain c. Tom Jones d. The Adventures of Huckleberry Finn Test 1. Who wrote The Adventures of Huckleberry Finn? a. Tom Sawyer b. Mark Twain c. Tom Jones d. Tom Finn 2. What town did Huck Finn live in? a. St. Paul b. St. Petersburg

More information

PATENTS. Pharmaceutical Product Patenting Strategies

PATENTS. Pharmaceutical Product Patenting Strategies PATENTS Pharmaceutical Product Patenting Strategies 1. What is a product patent? A product patent is a patent giving protection to a product as such, e.g. as an apparatus, a device or a chemical compound.

More information

Novartis extends commitment to help achieve final elimination of leprosy

Novartis extends commitment to help achieve final elimination of leprosy Novartis India Limited Sandoz House Shivsagar Estate Dr Annie Besant Road Worli, Mumbai 400 018 India MEDIA RELEASE MEDIA RELEASE MEDIA RELEASE Novartis extends commitment to help achieve final elimination

More information

How companies leverage quality and quality certifications to achieve competitive advantage

How companies leverage quality and quality certifications to achieve competitive advantage How companies leverage quality and quality certifications to achieve competitive advantage Eize de Boer Systems & Services Certification International Business Development Manager Pharma Supply Chain for

More information

Nurturing Australia s brightest minds

Nurturing Australia s brightest minds Nurturing Australia s brightest minds Investing in the health of Australia Health is now recognised as one of the most important global challenges facing both developed and developing countries Despite

More information

Best Practices for Launching Tech Ventures and Leveraging the University Mission Accelerating New Ventures

Best Practices for Launching Tech Ventures and Leveraging the University Mission Accelerating New Ventures Best Practices for Launching Tech Ventures and Leveraging the University Mission Accelerating New Ventures 2011 The University of Texas at Austin IC2 Institute 1 Overview Review of Traditional Innovation

More information

Examining the Evolving Offshore Business Process Outsourcing Model: A Practitioner s Perspective of BPO Generation 2.0

Examining the Evolving Offshore Business Process Outsourcing Model: A Practitioner s Perspective of BPO Generation 2.0 Leadership Perspective from Perot Systems Examining the Evolving Offshore Business Process Outsourcing Model: A Practitioner s Perspective of BPO Generation 2.0 The BPO Generation 2.0 model defines a more

More information

When it comes to health

When it comes to health When it comes to health Medical Evidence Matters EASIER, FASTER EVIDENCE-BASED DECISIONS What is Evidence-Based Medicine (EBM)? Evidence-based medicine is the conscientious, explicit and judicious use

More information

Global outlook: Healthcare

Global outlook: Healthcare Global outlook: Healthcare March 2014 healthcare 1 Today s presenters Ana Nicholls Managing Editor, Industry Briefing Economist Intelligence Unit Lauren Brayshaw Marketing executive Economist Intelligence

More information

White Paper. How Small Healthcare IT Companies Can Profit In the Years Ahead. Published by BrownIT Corporation, July 27, 2013.

White Paper. How Small Healthcare IT Companies Can Profit In the Years Ahead. Published by BrownIT Corporation, July 27, 2013. White Paper How Small Healthcare IT Companies Can Profit In the Years Ahead Published by BrownIT Corporation, July 27, 2013 Page 1 July 27, 2013 How Small Healthcare IT Companies Can Profit In the Years

More information

Technology Policy and Management Course 38E00100 "Immaterial Property Rights", Spring 2007, 1st Period. IMMATERIAL PROPERTY SYSTEM 31st January 2007

Technology Policy and Management Course 38E00100 Immaterial Property Rights, Spring 2007, 1st Period. IMMATERIAL PROPERTY SYSTEM 31st January 2007 Helsinki School of Economics Technology Policy and Management Course 38E00100 "Immaterial Property Rights", Spring 2007, 1st Period IMMATERIAL PROPERTY SYSTEM 31st January 2007 WELCOME! Olli Ilmarinen,

More information

Inventions & Patents: Marketing a New Idea

Inventions & Patents: Marketing a New Idea Inventions & Patents: Marketing a New Idea About Intellectual Property Intellectual Property (IP) refers to the rights assigned to individuals who have created an original work. This can include inventions,

More information

Investing in the United States

Investing in the United States Investing in the United States 13 May 2015 ehealth Week 2015 Global Markets: Tools for Transatlantic Trade Kim Tuminaro Senior Trade Officer U.S. Department of State SelectUSA.gov U.S. Investment and Business

More information

Road map for establishing Technology & Innovation Support Centers (TISC)

Road map for establishing Technology & Innovation Support Centers (TISC) Road map for establishing Technology & Innovation Support Centers (TISC) I. Background 1. Why: a. To allow users to benefit effectively from increased accessibility offered by internet searches (including

More information

DEVELOPING WORLD HEALTH PARTNERSHIPS DIRECTORY

DEVELOPING WORLD HEALTH PARTNERSHIPS DIRECTORY DEVELOPING WORLD HEALTH PARTNERSHIPS DIRECTORY OVER 250 HEALTH PARTNERSHIPS THAT MAKE A DIFFERENCE TO PEOPLE S LIVES The global health community needs to overcome both new and current challenges in the

More information

Louisiana We are so proud to announce that we are 100% debt free! Praise God! We started our business with over a million and a half dollars in debt.

Louisiana We are so proud to announce that we are 100% debt free! Praise God! We started our business with over a million and a half dollars in debt. Louisiana We are so proud to announce that we are 100% debt free! Praise God! We started our business with over a million and a half dollars in debt. God has been good to us and true to His Word. Brother

More information

University of the West of England, Bristol. Intellectual Property Policy

University of the West of England, Bristol. Intellectual Property Policy University of the West of England, Bristol Intellectual Property Policy 1 INTRODUCTION...2 1.1 EXTERNAL CONTEXT...2 1.2 CONTENT...2 1.3 STAKEHOLDERS...2 1.4 RAISING ISSUES...3 2 LEGAL OWNERSHIP OF INTELLECTUAL

More information

Wesleyan provides help when you need it most

Wesleyan provides help when you need it most Wesleyan provides help when you need it most 02 Personal Income Protection Plan Relax, You re covered At Wesleyan, we ve been providing specialist financial advice and solutions to professionals for over

More information

Intellectual Property in Horizon 2020 overview with a focus on comparison with FP7

Intellectual Property in Horizon 2020 overview with a focus on comparison with FP7 European IPR Helpdesk Intellectual Property in Horizon 2020 overview with a focus on comparison with FP7 The European IPR Helpdesk is managed by the European Commission s Executive Agency for Small and

More information

Revised 7/05. Copyright 2005 St. Jude Children's Research Hospital www.stjude.org Page 1 of 6

Revised 7/05. Copyright 2005 St. Jude Children's Research Hospital www.stjude.org Page 1 of 6 Antidepressants are drugs used, most often, to treat depression. Depression is a complex illness that involves sad and hopeless feelings that do not go away. Doctors sometimes order these drugs for other

More information

The Secrets of Successful Smart Energy Approaches

The Secrets of Successful Smart Energy Approaches 295 Plus: case study The Netherlands and: Post-Fukushima Japan turns to smart energy Where politics and markets meet Explaining the secrets of success Exclusive interviews with the world s foremost experts

More information

SPECIALTY DRUGS: IT S ABOUT HEALTH, VALUE AND PRICE

SPECIALTY DRUGS: IT S ABOUT HEALTH, VALUE AND PRICE SPECIALTY DRUGS: IT S ABOUT HEALTH, VALUE AND PRICE (OR, IF SPECIALTY DRUGS ARE SO COST EFFECTIVE, WHY CAN Y WE AFFORD THEM?) Sharon Levine MD June 11, 2015 What is a specialty drug? DefiniJons vary; different

More information

Intellectual Property

Intellectual Property Intellectual Property Protection Helpsheet When running a business you need to consider protecting your intellectual property which could be anything from your logo to inventions, products and designs.

More information

Don t Delay Hospice Care Referrals

Don t Delay Hospice Care Referrals Don t Delay Hospice Care Referrals Timely hospice admissions provide greater benefits. Among the Medicare population, about nine out of 10 deaths are associated with chronic illnesses, such as cancer,

More information

A Shopper s Guide to CANCER INSURANCE

A Shopper s Guide to CANCER INSURANCE A Shopper s Guide About the NAIC The National Association of Insurance Commissioners (NAIC) is the oldest association of state government officials. Its members consist of the chief insurance regulators

More information

Information for patients and the public and patient information about DNA / Biobanking across Europe

Information for patients and the public and patient information about DNA / Biobanking across Europe Information for patients and the public and patient information about DNA / Biobanking across Europe BIOBANKING / DNA BANKING SUMMARY: A biobank is a store of human biological material, used for the purposes

More information

Providing High-Quality Innovation and Technology Support Services University Experience and Best Practices. Professor Stanley Kowalski

Providing High-Quality Innovation and Technology Support Services University Experience and Best Practices. Professor Stanley Kowalski Providing High-Quality Innovation and Technology Support Services University Experience and Best Practices Professor Stanley Kowalski Overview: Technology Transfer Defined Mission and Policy Statutory

More information

Annual Report on Form 20-F

Annual Report on Form 20-F Annual Report on Form 20-F 2 Teva at a Glance Founded in 1901 by three young pharmacists, today Teva Pharmaceutical Industries Ltd. is a leader in the global pharmaceutical industry, providing medicines

More information

MSD Information Technology Global Innovation Center. Digitization and Health Information Transparency

MSD Information Technology Global Innovation Center. Digitization and Health Information Transparency MSD Information Technology Global Innovation Center Digitization and Health Information Transparency 10 February 2014 1 We are seeking energetic, forward thinking graduates to join our Information Technology

More information

Creating a Learning Health System in Michigan Wednesday, June 4, 2014

Creating a Learning Health System in Michigan Wednesday, June 4, 2014 Creating a Learning Health System in Michigan Wednesday, June 4, 2014 Joshua C. Rubin, JD, MBA, MPH, MPP Executive Program Officer for Learning Health System Initiatives University of Michigan School of

More information

Specialty Drug Hyperinflation:

Specialty Drug Hyperinflation: Specialty Drug Hyperinflation: The Risk to Patients and the Health Care System Specialty drugs 1 offer important hope for many patients with complex, hard-to-treat illnesses. While the price of specialty

More information

Orphan Pharma: pathfinders for an increasingly specialised industry

Orphan Pharma: pathfinders for an increasingly specialised industry Orphan Pharma: pathfinders for an increasingly specialised industry Foreword We are continuing our series by profiling the R&D and Clinical Development leadership of European and North American specialty

More information

Ryerson Digital Media Zone Online Resources Patent Essentials

Ryerson Digital Media Zone Online Resources Patent Essentials Maya Medeiros Lawyer, Patent Agent, Trademark Agent T: +1 416.216.4823 maya.medeiros@nortonrosefulbright.com http://www.nortonrosefulbright.com/people/99601/maya- medeiros PATENT ESSENTIALS WHAT IS A PATENT?

More information

Up to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data).

Up to $402,000. Insight HIV. Drug Class. 1.2 million people in the United States were living with HIV at the end of 2011 (most recent data). HIV Background, new developments, key strategies Drug Class Insight INTRODUCTION Human Immunodeficiency Virus (HIV) is the virus that can lead to Acquired Immunodeficiency Syndrome, or AIDS. No safe and

More information

Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research

Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research Anforderungen der Life-Science Industrie an die Hochschulen Hans Widmer Novartis Institutes for BioMedical Research There s nothing more extraordinary than a normal life 2 What does industry expect from

More information

Intellectual Property Rights Insurance. Slide 1

Intellectual Property Rights Insurance. Slide 1 Intellectual Property Rights Insurance Slide 1 LBT Services Ltd Ernest Kay M.Sc. Barrister, ACIPA, F.Inst Directors Patent Insurance - General Overview Available in the UK & USA > 20 years Small Inventors

More information

Intellectual Property Consulting

Intellectual Property Consulting Intellectual Property Consulting Charles River Associates provides valuation, litigation, and strategic consulting services related to intellectual property in a wide range of contexts. The skill and effectiveness

More information

Small and Medium-Sized Enterprises

Small and Medium-Sized Enterprises Kari Sipilä Small and Medium-Sized Enterprises D.Sc. (Techn.) h.c. and Intellectual Property Executive Director Brasov, Romania Foundation for Finnish Inventions May 14-15, 2002 Espoo, Finland INNOVATION

More information

Biosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies

Biosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies Biosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies Fern Barkalow, Ph.D, Senior Analyst, Oncology Citeline One of the biggest challenges facing biosimilar drug developers is

More information

FDA approves Rituxan/MabThera for first-line maintenance use in follicular lymphoma

FDA approves Rituxan/MabThera for first-line maintenance use in follicular lymphoma Media Release Basel, 31 January 2011 FDA approves Rituxan/MabThera for first-line maintenance use in follicular lymphoma Approval provides option that improves the length of time people with incurable

More information

TABLE OF CONTENTS. 1. Introduction. 1.1. Dementia and Alzheimer Prevalence. 2. Global Alzheimer Market and Performance. 2.1.

TABLE OF CONTENTS. 1. Introduction. 1.1. Dementia and Alzheimer Prevalence. 2. Global Alzheimer Market and Performance. 2.1. 1 Disclaimer The research reports provided by AM Mindpower Solutions are for the personal information of the authorised recipient and is not for public distribution and should not be reproduced or redistributed

More information

When treating a disease is bad business: orphan and neglected diseases

When treating a disease is bad business: orphan and neglected diseases When treating a disease is bad business: orphan and neglected diseases Rocío Acuña Hidalgo Introduction Over the past decades, the development of thousands of new drugs to treat diseases has improved the

More information

Pharmaceutical Report Royalty Purchasing Industry. Thomas R. Wells

Pharmaceutical Report Royalty Purchasing Industry. Thomas R. Wells Pharmaceutical Report Royalty Purchasing Industry Thomas R. Wells Table of Contents Industry Overview 2 How Transactions Work 2 Advantages & Disadvantages for Inventors and Investors 4 Major Investors

More information

Measuring the Success of Your Mobile Strategy

Measuring the Success of Your Mobile Strategy WHITEPAPER / MOBILE ANALYTICS Measuring the Success of Your Mobile Strategy Applying the lessons learned over the past 15 years, digital marketers now use web analytics to measure what matters to their

More information

Atos KPMG Consulting 2003. The future of Heath Care in Emerging Markets Guy Ellena Rio de Janeiro, November 2009

Atos KPMG Consulting 2003. The future of Heath Care in Emerging Markets Guy Ellena Rio de Janeiro, November 2009 Atos KPMG Consulting 2003 The future of Heath Care in Emerging Markets Guy Ellena Rio de Janeiro, November 2009 Agenda Introduction Trends : Demand, Supply and Cost Opportunities IFC & Health Care in Emerging

More information

Healthcare 2014: Driving efficiency through technology. Part two: Chronic Disease Management and Preventative Health

Healthcare 2014: Driving efficiency through technology. Part two: Chronic Disease Management and Preventative Health Healthcare 2014: Driving efficiency through technology Alex Holderness for Australian Healthcare Week 2014 Technology is sitting right at the heart of the healthcare efficiency drive and it s easy to see

More information

Materials Lesson Objectives

Materials Lesson Objectives 165 Materials 1. Play money ($2,000 per student) 2. Candy (Different types, 10 per student) 3. Savvy student reward, which is an item perceived by the students to be of greater value than all the candy

More information

TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending...

TABLE OF CONTENTS. Introduction...1. Chapter1 AdvancesinTreatment...2. Chapter2 MedicinesinDevelopment...11. Chapter3 ValueandSpending... CANCER TABLE OF CONTENTS Introduction...1 Chapter1 AdvancesinTreatment...2 Chapter2 MedicinesinDevelopment......11 Chapter3 ValueandSpending......15 Chapter4 Conclusion...22 INTRODUCTION Researchers and

More information

Financial Wellness & Education Life Insurance. Understanding life insurance

Financial Wellness & Education Life Insurance. Understanding life insurance Financial Wellness & Education Life Insurance Understanding life insurance For all of life s stages People require financial protection at virtually every stage of their lives. As you get older, the amount

More information

Exploring the Role of Vitamins in Achieving a Healthy Heart

Exploring the Role of Vitamins in Achieving a Healthy Heart Exploring the Role of Vitamins in Achieving a Healthy Heart There are many avenues you can take to keep your heart healthy. The first step you should take is to have a medical professional evaluate the

More information

PRESCRIPTION MEDICINES: COSTS IN CONTEXT

PRESCRIPTION MEDICINES: COSTS IN CONTEXT PRESCRIPTION MEDICINES: COSTS IN CONTEXT 2015 Since 2000, biopharmaceutical companies have brought MORE THAN 500 NEW TREATMENTS AND CURES to U.S. patients In the last 100 years, medicines have helped raise

More information

America s Oral Health

America s Oral Health a me r i c a s Most Trusted D e n t a l l P a n America s Oral Health The Role of Dental Benefits Compiled and published by Delta Dental Plans Association, this report cites data from a number of industry

More information

Executive Summary. Anglers 50 million U.S. active fishers 700 million active fishers around the world. Gamers 93 million of U.S.

Executive Summary. Anglers 50 million U.S. active fishers 700 million active fishers around the world. Gamers 93 million of U.S. Find this presentation online at https://robofisher.com/investorspresentation.pdf robot driven online fishing Executive Summary RoboFisher Distant real fishing from your personal gadget a new recreational

More information

PLANNING FOR RETIREMENT: THE HEALTHCARE WILDCARD. Understanding healthcare costs in retirement // Misconceptions about Medicare // Taking action

PLANNING FOR RETIREMENT: THE HEALTHCARE WILDCARD. Understanding healthcare costs in retirement // Misconceptions about Medicare // Taking action PLANNING FOR RETIREMENT: THE HEALTHCARE WILDCARD Understanding healthcare costs in retirement // Misconceptions about Medicare // Taking action KEY TAKEAWAYS Even with supplemental insurance and Medicare,

More information

Parent s Guide to CHILDHOOD IMMUNIZATIONS

Parent s Guide to CHILDHOOD IMMUNIZATIONS Part One Vaccine-Preventable Part Three More Diseases About Vaccines and Childhood Vaccines 30 Parent s Guide to CHILDHOOD IMMUNIZATIONS Part 3: More About Vaccines How do vaccines work? To understand

More information

IP is your business. Intellectual Property (IP) is one of your most important assets.

IP is your business. Intellectual Property (IP) is one of your most important assets. IP is your business Intellectual Property (IP) is one of your most important assets. IP is your business What is Intellectual Property? A: Intellectual property (IP) is a term that describes the application

More information

Richard T. Clark Chief Executive Officer and President. Executing on Our Strategy

Richard T. Clark Chief Executive Officer and President. Executing on Our Strategy Richard T. Clark Chief Executive Officer and President Executing on Our Strategy Merck s Plan to Win: Preparing for Our Future Success BECOME THE MOST TRUSTED INDUSTRY LEADER IN DELIVERING VALUE TO CUSTOMERS

More information

Visualizing the Future of MS Research: ACP s Repository Holds the Map

Visualizing the Future of MS Research: ACP s Repository Holds the Map Dear Friends, This issue is all about Big Data to Knowledge, otherwise known as BD2K. This refers to society s growing ability to gather a wealth of information about people in our case, people with MS

More information

Clinical Trial Trends Outline Complexity for Supply Chain. Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken.

Clinical Trial Trends Outline Complexity for Supply Chain. Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken. Clinical Trial Trends Outline Complexity for Supply Chain Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken.com 29 May 2013 Biotechnology Sales on the Rise Source: EvaluatePharma

More information

LONG-TERM CARE INSURANCE. You make the decisions

LONG-TERM CARE INSURANCE. You make the decisions LONG-TERM CARE INSURANCE You make the decisions EATING, BATHING, DRESSING, GETTING OUT OF BED... ROUTINE DAILY ACTIVITIES SOMEDAY WE MAY NOT BE ABLE TO DO ON OUR OWN Someday, because of your age or an

More information

Bayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups

Bayer Invests Heavily in R&D and is committed to innovation Sustained Innovation Output from all Subgroups Open Innovation@BayerHealthCare Dr. Daniel Forler External Innovation Therapeutics Global Drug Discovery, Bayer HealthCare ASTP-Proton Conference Page 1 Bayer Invests Heavily in R&D and is committed to

More information

GLOBAL ACCESS LICENSING FRAMEWORK

GLOBAL ACCESS LICENSING FRAMEWORK GLOBAL ACCESS LICENSING FRAMEWORK Every university-developed technology with potential for further development into a drug, vaccine, or medical diagnostic should be licensed with a concrete and transparent

More information

The Role of Universities in Essential Medicine

The Role of Universities in Essential Medicine The Role of Universities in Essential Medicine Presented by: Gloria Tavera Thanks To: Sam Chaifetz (Yale) 2004 Hillary Freudenthal (Berkeley) 2005 Amit Khera (University of Pennsylvania School of Medicine)

More information

Business from Research Innovation at VTT

Business from Research Innovation at VTT Business from Research Innovation at VTT Vesi-ohjelman vuosiseminaari, 22.11.2011 Timo Pulli, Business Development Manager timo.pulli@vtt.fi, +358 40 720 7152 VTT Technical Research Centre of Finland 2

More information

Value Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector

Value Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector Value Creation through Business Innovation in the Pharmaceutical and Medical Technology Sector Fred Nijland Annemarie van Hoogstraten Nanning de Jong 1 Summary The Dutch market for the pharmaceutical and

More information

SINO-RUSSIAN BUSINESS: FIVE TIPS ON RUSSIAN INTELLECTUAL PROPERTY LAW

SINO-RUSSIAN BUSINESS: FIVE TIPS ON RUSSIAN INTELLECTUAL PROPERTY LAW SINO-RUSSIAN BUSINESS: FIVE TIPS ON RUSSIAN INTELLECTUAL PROPERTY LAW Emerging trade relations give rise to various concerns, and in today s world the legal aspects of intellectual property are growing

More information

ENTERPRISE APP QUALITY. Why the world s biggest brands turn to Applause to achieve 360 app quality

ENTERPRISE APP QUALITY. Why the world s biggest brands turn to Applause to achieve 360 app quality ENTERPRISE APP QUALITY Why the world s biggest brands turn to Applause to achieve 360 app quality 01 INTRODUCTION WHY ENTERPRISES PARTNER WITH APPLAUSE S ome of the world s biggest brands turn to Applause

More information

PATENT BOX HOW TO MAXIMISE THE BENEFITS

PATENT BOX HOW TO MAXIMISE THE BENEFITS PATENT BOX HOW TO MAXIMISE THE BENEFITS On 1 April 2013 the government introduced a low tax regime applicable to a company s profits, derived from the commercial exploitation of inventions protected by

More information

Michele Genovese DG Research and Innovation Specific International Cooperation Activities

Michele Genovese DG Research and Innovation Specific International Cooperation Activities Michele Genovese DG Research and Innovation Specific International Cooperation Activities 1 2 1. Innovation in a changing, challenging world New Priorities 3 Recent changes in the global economic system

More information

the solution. I think too much of the health care issues we re faced with as opposed to the problem.

the solution. I think too much of the health care issues we re faced with as opposed to the problem. Introduction: Hi I m Sherrie Bossing and I manage Lilly s corporate brand and volunteer strategy worldwide. I m joined today with Dr. Jack Harris who is the Vice President responsible for US Medical Division,

More information

Future of Healthcare: How IT Savvy Power Patients Will Drive a Healthcare Revolution. Dorman Followwill Partner Frost & Sullivan

Future of Healthcare: How IT Savvy Power Patients Will Drive a Healthcare Revolution. Dorman Followwill Partner Frost & Sullivan Future of Healthcare: How IT Savvy Power Patients Will Drive a Healthcare Revolution Dorman Followwill Partner Frost & Sullivan Forces Shaping the Future of Health, Wellness and Wellbeing Molecular & Personalised

More information

Roche in Switzerland Innovation is our home

Roche in Switzerland Innovation is our home Roche in Switzerland Innovation is our home Roche s sites in Switzerland in context Roche was founded by Fritz Hoffmann-La Roche on 1 October 1896. He was one of the first people to recognise that major

More information

HOT TOPICS IN IN HEALTH CARE REFORM

HOT TOPICS IN IN HEALTH CARE REFORM By Felicia Fuller Publications Manager, DAC Patient Recruitment Services The Patient Protection and Affordable Care Act (ACA), colloquially known as Obamacare, is in full effect and its impact is palpable

More information

Negotiating Royalties - Commercializing Intellectual Property Assets

Negotiating Royalties - Commercializing Intellectual Property Assets Negotiating Royalties - Commercializing Intellectual Property Assets Approaches by the Consejo Superior de Investigaciones Científicas (Spanish National Research Council) Dr. José Pablo ZAMORANO Licensing

More information

IP Audit and Management

IP Audit and Management WIPO Training of Trainers Program on Asset Management by Small and IP Audit and Management 10 12 June 2013 Presented by Mowafak Al Yafi Ph.D Discussion points What is IP Audit What are the types of assets

More information

Policy for the Management of Intellectual Property

Policy for the Management of Intellectual Property Policy for the Management of Intellectual Property elibrary ID Reference No: GOV-POL-004-09 Newly developed Trust-wide CBRs will be allocated an elibrary reference number following submission of eform

More information

Thanks a lot for the introduction.

Thanks a lot for the introduction. Thanks a lot for the introduction. I was really looking forward to be here in Sao Paulo. Some of you know me already. My name is Thomas Goletz. I m one of the cofounders and investors of Netresearch App

More information

Profiting from Non-Technological Innovation: The Value of Patenting. Novak druce centre insights No. 8

Profiting from Non-Technological Innovation: The Value of Patenting. Novak druce centre insights No. 8 Profiting from Non-Technological Innovation: The Value of Patenting Business METHODS Novak druce centre insights No. 8 contents 01 Introduction: An Unexplored Area 02 Patenting Non-Technological Innovation

More information